This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Nhwa Pharmaceutical Co., Ltd, Shujing Biopharma Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jun Qin: Innovator in Neuropsychiatric Medicaments
Introduction
Jun Qin is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neuropsychiatric diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Jun Qin holds a patent for a "Heterocyclic substituted fused γ-carboline derivative, preparation method therefor, intermediate thereof and use thereof." This invention relates to a unique compound structure that can be utilized in the preparation of medicaments for neuropsychiatric conditions. The compound is represented by a specific formula, indicating its potential therapeutic applications.
Career Highlights
Throughout his career, Jun Qin has worked with prominent companies in the pharmaceutical industry. He has been associated with Shujing Biopharma Co., Ltd and Jiangsu Nhwa Pharmaceutical Co., Ltd, where he has contributed to various research and development projects. His experience in these organizations has further solidified his reputation as an innovator in the field.
Collaborations
Jun Qin has collaborated with several professionals in his field, including Zehong Wan and Jiaquan Feng. These partnerships have allowed him to enhance his research and expand the impact of his inventions.
Conclusion
Jun Qin's contributions to the field of neuropsychiatric medicaments through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to inspire advancements in medicinal chemistry and offers hope for effective treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile